Security Snapshot

Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT) Institutional Ownership

CUSIP: 00650F109

13F Institutional Holders and Ownership History from Q3 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

294

Shares (Excl. Options)

151,849,504

Price

$13.88

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+1,238,479
Value change
+$6,707,442
Number of holders
294
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
159,541,000
SEC-reported price per share
$14.53
Insider filing price
$14.53
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ADPT - Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share is tracked under CUSIP 00650F109.
  • 294 institutions reported positions in Q1 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 282 to 294 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $2,440,647,272 to $2,107,726,135.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 294 institutions filings for Q1 2026.

Open SEC evidence

Security key

00650F109

Latest holder period

Q1 2026

13F holders

294

13D/G owners

7

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
ADPT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VIKING GLOBAL INVESTORS LP 19% $416,312,667 29,993,708 VIKING GLOBAL INVESTORS LP 31 Mar 2026
BlackRock, Inc. 7.9% +17% $194,757,356 +$33,318,016 11,992,448 +21% BlackRock, Inc. 31 Dec 2025
Nikko Asset Management Americas, Inc. 4.6% $53,981,782 6,833,137 Nikko Asset Management Americas, Inc. 31 Dec 2024
Sumitomo Mitsui Trust Group, Inc. 4.6% $53,981,782 6,833,137 Sumitomo Mitsui Trust Group, Inc. 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC 4.3% $49,711,809 6,292,634 Millennium Management LLC 31 Dec 2024
Rubric Capital Management LP 4.1% $72,889,139 6,256,847 Rubric Capital Management LP 30 Jun 2025
ARK Investment Management LLC 2.9% -27% $40,863,635 -$15,506,311 4,398,669 -28% ARK Investment Management LLC 31 May 2025

As of 31 Mar 2026, 294 institutional investors reported holding 151,849,504 shares of Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT). This represents 95% of the company’s total 159,541,000 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
68%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VIKING GLOBAL INVESTORS LP 19% 29,993,708 0% 1.2% $416,312,667
BlackRock, Inc. 8.3% 13,303,025 -0.23% 0% $184,645,993
VANGUARD CAPITAL MANAGEMENT LLC 3.8% 6,094,144 0% 0% $84,586,719
WESTFIELD CAPITAL MANAGEMENT CO LP 3.4% 5,436,718 +34% 0.32% $75,461,646
VANGUARD PORTFOLIO MANAGEMENT LLC 2.8% 4,491,474 0% 0% $62,341,659
Invesco Ltd. 2.8% 4,450,066 +43% 0.01% $61,766,916
WELLINGTON MANAGEMENT GROUP LLP 2.4% 3,857,422 +78% 0.01% $53,541,017
GEODE CAPITAL MANAGEMENT, LLC 2.3% 3,636,054 +3.5% 0% $50,476,677
LORD, ABBETT & CO. LLC 2.2% 3,536,103 +15% 0.16% $49,081,000
GOLDMAN SACHS GROUP INC 2% 3,242,077 +12% 0.01% $45,000,029
STATE STREET CORP 2% 3,227,245 +1.4% 0% $44,794,161
AMERIPRISE FINANCIAL INC 1.9% 3,017,341 +16% 0.01% $41,880,713
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 1.7% 2,688,081 0.04% $37,310,564
ARK Investment Management LLC 1.3% 2,092,969 -2.2% 0.23% $29,050,406
FRED ALGER MANAGEMENT, LLC 1.3% 2,063,146 -8.1% 0.13% $28,636,466
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.3% 1,995,202 -18% 0.01% $27,693,404
D. E. Shaw & Co., Inc. 1.2% 1,965,610 +3.3% 0.02% $27,282,666
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.2% 1,881,183 -3.1% 0.04% $26,111,000
Driehaus Capital Management LLC 1.1% 1,750,601 -37% 0.18% $24,298,342
Aristotle Atlantic Partners, LLC 1.1% 1,714,346 -7% 1.1% $23,795,122
PRINCIPAL FINANCIAL GROUP INC 1.1% 1,704,887 +9.8% 0.01% $23,663,831
Sumitomo Mitsui Trust Group, Inc. 1% 1,595,370 -18% 0.01% $22,143,736
Amova Asset Management Americas, Inc. 1% 1,595,370 -18% 0.31% $22,143,736
PRICE T ROWE ASSOCIATES INC /MD/ 0.98% 1,566,213 -64% 0% $21,741,000
NORTHERN TRUST CORP 0.87% 1,392,332 +19% 0% $19,325,568

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
31
Latest
Q1 2026
Rows shown
1-25 of 31
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 151,849,504 $2,107,726,135 +$6,707,442 $13.88 294
2025 Q4 150,282,518 $2,440,647,272 +$33,879,510 $16.24 282
2025 Q3 145,422,829 $2,175,120,073 -$14,779,461 $14.96 269
2025 Q2 148,178,882 $1,726,248,551 -$46,396,273 $11.65 240
2025 Q1 152,930,142 $1,136,093,247 +$68,698,942 $7.43 222
2024 Q4 143,282,424 $858,588,192 +$3,881,916 $6.00 204
2024 Q3 143,105,692 $732,467,776 -$27,674,373 $5.12 184
2024 Q2 148,655,164 $538,029,201 +$26,127,842 $3.62 173
2024 Q1 142,447,362 $456,622,976 -$10,170,998 $3.21 186
2023 Q4 143,639,172 $703,966,709 +$9,702,761 $4.90 194
2023 Q3 140,492,459 $765,707,625 +$15,429,772 $5.45 187
2023 Q2 137,082,822 $919,786,637 +$21,850,661 $6.71 208
2023 Q1 133,849,942 $1,179,397,231 +$14,000,370 $8.83 223
2022 Q4 132,787,161 $1,014,264,343 +$14,824,828 $7.64 216
2022 Q3 131,007,037 $931,519,109 -$31,344,186 $7.12 205
2022 Q2 134,391,278 $1,083,708,756 +$49,040,887 $8.09 196
2022 Q1 125,563,937 $1,741,620,797 -$42,426,089 $13.88 207
2021 Q4 123,444,543 $3,462,001,567 +$139,816,088 $28.06 208
2021 Q3 117,860,461 $4,003,739,752 -$434,478 $33.99 212
2021 Q2 117,427,979 $4,796,005,013 +$143,202,294 $40.86 226
2021 Q1 113,768,226 $4,579,995,207 -$122,834,155 $40.26 238
2020 Q4 114,044,316 $6,743,577,628 +$149,068,690 $59.13 244
2020 Q3 111,322,127 $5,410,179,736 +$503,359,137 $48.63 206
2020 Q2 101,046,823 $4,886,712,149 +$212,566,003 $48.38 192
2020 Q1 96,830,392 $2,689,585,555 +$284,953,611 $27.78 144
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .